Millipore Sigma Vibrant Logo
Home>Events>BioProcess International US West
BioProcess International US West
Booth 405

BioProcess International US West

March 11 - 14, 2019, Santa Clara Convention Center, Santa Clara, CA

Vibrant M Merck

Join us for an outlook on the future of bioprocessing!

Market forces, capacity constraints, and government policies have driven the bioprocess industry to evaluate new technologies in mAb production with goals to maximize manufacturing flexibility and efficiency while minimizing risk and product cost. Focus is needed on technologies offering the highest return on investment based on ease-of-implementation, regulatory acceptance, and COGs reduction.

Come by booth 405 to discover our process intensification technologies enabling you to confidently enter the era of Next Generation Bioprocessing:

  • Intensified Upstream Suite
  • Mobius® Power MIX Single-Use Mixing Systems
  • Buffer Concentrates
  • Intensified Capture Technologies
  • Pellicon® Single-Pass TFF
  • Flow-Through Polishing Toolbox

Visit the Event Website

Come and listen to our technical experts!

Experts Roundtable
Beyond Bioprocessing 4.0: Enabling Technologies, Analytics, & Leveraging the new
Digital Era

March 12, 2019  |  10:00 - 11:30 AM

This panel discussion will focus on case studies and perspectives from industry experts on the implementation of Bioprocessing 4.0 today, remaining gaps and barriers to overcome while addressing the following topics:

  • Enabling technologies for process intensification
  • Advanced analytical technologies
  • Software and automation for smart facilities


  • Nuno Pinto, Senior Scientist, MSD
  • Thibault Dutronc, Associate Scientist, Merck
  • Alessandro Butte, Senior Scientist and lecturer at ETH Zurich, Co-founder and CEO of DataHow at ETH Zurich
  • Michael Phillips, Head of Next Generation Bioprocessing Applications & Innovation, Merck


Merrilee Whitney, Head of BioContinuum™ Platform for Next Generation Bioprocessing, MilliporeSigma

A Holistic Approach to Upstream Viral Safety

March 13, 2019  |  01:40 - 02:10 PM

All biologics production processes focus on preventing adventitious microorganisms from entering upstream processes. There are numerous technologies to minimize contamination risks but they are not all suitable for every process. We will discuss the strengths and limitations of these technologies and explain how they can be integrated with advances in testing into a holistic upstream biosafety strategy.


Craig Jackson, Senior Product Manager, Biosafety, Process Solutions, MilliporeSigma

Venue Information

Santa Clara Convention Center
5001 Great America Pkwy.
Santa Clara, CA 95054

Let's continue the conversation over a glass of tasty Californian wine!

BPI Networking
Evening Reception

Tuesday, March 12
5:30 – 6:30 PM

Exhibition show floor